T
Trigiant Group Ltd
HKEX:1300
Trigiant Group Ltd
HKEX:1300
Price:
0.96
HKD
-3.03%
Market Closed
Market Cap:
HK$1.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
T
|
Trigiant Group Ltd
HKEX:1300
|
CN |
|
Y
|
Yubo International Biotech Ltd
OTC:YBGJ
|
CN |
|
Constellation Brands Inc
NYSE:STZ
|
US |
|
Aarti Drugs Ltd
NSE:AARTIDRUGS
|
IN |
|
A
|
Amplifon SpA
LSE:0N61
|
IT |
Income Statement
Earnings Waterfall
Trigiant Group Ltd
Trigiant Group Ltd
Income Statement
Trigiant Group Ltd
Trigiant Group Ltd
Currency: CNY
| Jun-2013 | Dec-2013 | Jun-2014 | Dec-2014 | Jun-2015 | Dec-2015 | Jun-2016 | Dec-2016 | Jun-2017 | Dec-2017 | Jun-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
73
|
0
|
60
|
26
|
57
|
0
|
74
|
0
|
65
|
33
|
67
|
66
|
65
|
0
|
62
|
0
|
55
|
0
|
49
|
0
|
0
|
|
| Revenue |
2 402
N/A
|
2 458
+2%
|
2 545
+4%
|
2 658
+4%
|
2 796
+5%
|
2 913
+4%
|
2 759
-5%
|
2 921
+6%
|
3 051
+4%
|
3 201
+5%
|
3 417
+7%
|
3 469
+2%
|
3 891
+12%
|
3 542
-9%
|
2 596
-27%
|
2 873
+11%
|
3 039
+6%
|
2 862
-6%
|
2 783
-3%
|
2 630
-5%
|
2 636
+0%
|
2 506
-5%
|
2 414
-4%
|
2 509
+4%
|
2 586
+3%
|
2 639
+2%
|
|
| Gross Profit | |||||||||||||||||||||||||||
| Cost of Revenue |
(1 849)
|
(1 893)
|
(1 965)
|
(2 065)
|
(2 177)
|
(2 263)
|
(2 161)
|
(2 309)
|
(2 434)
|
(2 573)
|
(2 752)
|
(2 797)
|
(3 139)
|
(2 866)
|
(2 120)
|
(2 362)
|
(2 529)
|
(2 439)
|
(2 387)
|
(2 278)
|
(2 305)
|
(2 189)
|
(2 113)
|
(2 216)
|
(2 295)
|
(2 356)
|
|
| Gross Profit |
553
N/A
|
565
+2%
|
580
+3%
|
593
+2%
|
619
+4%
|
650
+5%
|
598
-8%
|
612
+2%
|
617
+1%
|
628
+2%
|
665
+6%
|
672
+1%
|
752
+12%
|
676
-10%
|
477
-29%
|
511
+7%
|
510
0%
|
424
-17%
|
396
-7%
|
352
-11%
|
331
-6%
|
317
-4%
|
301
-5%
|
294
-3%
|
291
-1%
|
282
-3%
|
|
| Operating Income | |||||||||||||||||||||||||||
| Operating Expenses |
(142)
|
(136)
|
(120)
|
(121)
|
(148)
|
(156)
|
(159)
|
(156)
|
(148)
|
(155)
|
(242)
|
(209)
|
(205)
|
(212)
|
(318)
|
(348)
|
(249)
|
(139)
|
(103)
|
(330)
|
(344)
|
(300)
|
(278)
|
(257)
|
(275)
|
(111)
|
|
| Selling, General & Administrative |
(120)
|
(117)
|
(102)
|
(99)
|
(115)
|
(115)
|
(115)
|
(117)
|
(112)
|
(107)
|
(142)
|
(162)
|
(152)
|
(157)
|
(264)
|
(274)
|
(185)
|
(75)
|
(54)
|
(293)
|
(306)
|
(266)
|
(249)
|
(217)
|
(228)
|
(62)
|
|
| Research & Development |
(27)
|
(24)
|
(23)
|
(27)
|
(37)
|
(47)
|
(50)
|
(51)
|
(52)
|
(56)
|
(57)
|
(58)
|
(62)
|
(62)
|
(60)
|
(60)
|
(62)
|
(58)
|
(50)
|
(44)
|
(45)
|
(50)
|
(55)
|
(54)
|
(52)
|
(50)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(20)
|
(7)
|
(15)
|
(7)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Operating Expenses |
5
|
4
|
5
|
5
|
4
|
6
|
6
|
12
|
16
|
9
|
(43)
|
12
|
10
|
6
|
6
|
7
|
6
|
8
|
9
|
7
|
6
|
17
|
26
|
14
|
4
|
1
|
|
| Operating Income |
412
N/A
|
429
+4%
|
460
+7%
|
472
+3%
|
471
0%
|
494
+5%
|
439
-11%
|
456
+4%
|
469
+3%
|
473
+1%
|
423
-11%
|
463
+10%
|
547
+18%
|
464
-15%
|
158
-66%
|
164
+3%
|
261
+60%
|
285
+9%
|
293
+3%
|
22
-92%
|
(13)
N/A
|
17
N/A
|
23
+37%
|
36
+56%
|
16
-56%
|
171
+979%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||
| Interest Income Expense |
(60)
|
(49)
|
(88)
|
(30)
|
(26)
|
(73)
|
(37)
|
(49)
|
(37)
|
(33)
|
(39)
|
(52)
|
(58)
|
(47)
|
(52)
|
(58)
|
(56)
|
(55)
|
(51)
|
(47)
|
(44)
|
(42)
|
(42)
|
(40)
|
(39)
|
(41)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
(63)
|
(144)
|
(135)
|
(91)
|
(89)
|
0
|
0
|
0
|
0
|
(94)
|
(249)
|
(155)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
352
N/A
|
380
+8%
|
372
-2%
|
442
+19%
|
445
+1%
|
359
-19%
|
258
-28%
|
271
+5%
|
340
+26%
|
351
+3%
|
383
+9%
|
412
+7%
|
489
+19%
|
416
-15%
|
12
-97%
|
(143)
N/A
|
50
N/A
|
230
+358%
|
243
+5%
|
(24)
N/A
|
(57)
-134%
|
(25)
+55%
|
(18)
+28%
|
(3)
+82%
|
(23)
-599%
|
129
N/A
|
|
| Net Income | |||||||||||||||||||||||||||
| Tax Provision |
(62)
|
(67)
|
(68)
|
(73)
|
(74)
|
(57)
|
(23)
|
(49)
|
(71)
|
(59)
|
(62)
|
(66)
|
(76)
|
(57)
|
(13)
|
4
|
(11)
|
(22)
|
(38)
|
(32)
|
(15)
|
3
|
2
|
(5)
|
(1)
|
(24)
|
|
| Income from Continuing Operations |
290
|
314
|
304
|
369
|
371
|
302
|
234
|
222
|
270
|
292
|
321
|
345
|
413
|
359
|
(0)
|
(139)
|
39
|
207
|
204
|
(56)
|
(72)
|
(23)
|
(16)
|
(8)
|
(24)
|
105
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
(16)
|
(27)
|
(23)
|
(29)
|
(17)
|
(15)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
290
N/A
|
314
+8%
|
304
-3%
|
369
+21%
|
355
-4%
|
275
-22%
|
211
-23%
|
193
-9%
|
238
+24%
|
277
+16%
|
321
+16%
|
345
+8%
|
413
+19%
|
359
-13%
|
(0)
N/A
|
(139)
-74 426%
|
39
N/A
|
207
+430%
|
204
-2%
|
(56)
N/A
|
(72)
-27%
|
(23)
+68%
|
(16)
+28%
|
(8)
+51%
|
(24)
-201%
|
105
N/A
|
|
| EPS (Diluted) |
0.28
N/A
|
0.31
+11%
|
0.28
-10%
|
0.33
+18%
|
0.27
-18%
|
0.19
-30%
|
0.14
-26%
|
0.12
-14%
|
0.15
+25%
|
0.16
+7%
|
0.18
+12%
|
0.19
+6%
|
0.23
+21%
|
0.2
-13%
|
0
N/A
|
-0.08
N/A
|
0.02
N/A
|
0.12
+500%
|
0.11
-8%
|
-0.03
N/A
|
-0.04
-33%
|
-0.01
+75%
|
-0.01
N/A
|
0
N/A
|
-0.01
N/A
|
0.06
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
